Valuation: AstraZeneca PLC

Market Cap 299B 262B 241B 224B 425B 28,508B 432B 2,888B 1,123B 14,013B 1,124B 1,100B 48,288B P/E 2026 *
24.1x
P/E 2027 * 21.2x
Enterprise Value 319B 279B 256B 239B 453B 30,341B 459B 3,073B 1,195B 14,914B 1,196B 1,170B 51,393B EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.65x
Free-Float
96.63%
Yield 2026 *
1.73%
Yield 2027 * 1.82%
1 day-3.00%
1 week-0.76%
Current month+0.64%
1 month+2.86%
3 months-5.13%
6 months+1.08%
Current year+2.90%
1 week 13,838
Extreme 13838
14,686
1 month 11,364
Extreme 11364
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,148
Extreme 10148
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-2.98%-0.76%+38.87%+37.39% 299B
-2.19%+0.48%+55.50%+160.66% 1,082B
-2.51%+3.29%+68.60%+61.56% 633B
-2.00%+3.05%+37.93%+89.70% 461B
-2.99%+1.37%+31.00%+23.05% 338B
-2.11%+0.38%+29.78%+44.50% 291B
-2.29%+2.76%-26.65%-40.20% 222B
-2.61%+4.41%+25.45%+65.64% 202B
-1.29%+2.65%+17.47%+69.95% 163B
-2.18%+0.12%-4.18%-33.30% 139B
Average -2.23%+4.28%+27.38%+47.90% 383.1B
Weighted average by Cap. -2.26%+5.33%+40.02%+77.62%

Financials

2026 *2027 *
Net sales 63.26B 55.3B 50.82B 47.37B 89.85B 6,023B 91.21B 610B 237B 2,961B 237B 232B 10,202B 66.91B 58.49B 53.75B 50.1B 95.03B 6,370B 96.47B 645B 251B 3,131B 251B 246B 10,791B
Net income 12.46B 10.9B 10.01B 9.33B 17.7B 1,187B 17.97B 120B 46.73B 583B 46.79B 45.78B 2,010B 13.97B 12.21B 11.22B 10.46B 19.84B 1,330B 20.14B 135B 52.37B 654B 52.43B 51.3B 2,253B
Net Debt 19.25B 16.83B 15.47B 14.42B 27.34B 1,833B 27.76B 186B 72.18B 901B 72.26B 70.7B 3,105B 11.76B 10.28B 9.44B 8.8B 16.7B 1,119B 16.95B 113B 44.08B 550B 44.13B 43.18B 1,896B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-06 GBX 13,978.00 -3.31% 617,101
26-07-03 GBX 14,456.00 -0.56% 653,264
26-07-02 GBX 14,538.00 +4.94% 2,810,574
26-07-01 GBX 13,854.00 -1.74% 1,804,499
26-06-30 GBX 14,100.00 -1.38% 2,513,351
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
193.04USD
Average target price
217.23USD
Spread / Average Target
+12.53%

Quarterly revenue - Rate of surprise